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The mechanism by which the inflammatory enzyme prostaglandin H 2 synthase-1 (PGHS-1) deactivates remains undefined. This study aimed to determine stabilizing parameters of PGHS-1 and identify factors leading to deactivation by nitrogen oxide species (NO x ). Purified PGHS-1 was stabilized when solubilized in β-octylglucoside (rather than Tween-20 or CHAPS) and when reconstituted with hemin chloride (rather than hematin). Peroxynitrite (ONOO -) activated the peroxidase site of PGHS-1 independently of the cyclooxygenase site. Following ONOO -exposure, holoPGHS-1 could not metabolize arachidonic acid and was structurally compromised, whereas apoPGHS-1 retained full activity once reconstituted with heme. After incubation of holoPGHS-1 with ONOO -, heme absorbance was diminished but to a lesser extent than the loss in enzymatic function, suggesting the contribution of more than one process to enzyme inactivation. Hydroperoxide scavengers improved enzyme activity, whereas hydroxyl radical ( Multimer formation was also observed and required heme but could be attenuated by arachidonic acid substrate. We conclude that the heme plays a role in catalyzing Tyr 385 nitration by ONOO
INTRODUCTION
Eicosanoids such as the prostaglandins, thromboxanes and leukotrienes that are formed from arachidonic acid metabolism regulate vascular tone and platelet aggregation (1) . Alterations in eicosanoid metabolism occur during the pathogenesis of inflammatory diseases (2) but the mechanisms are not well established.
Eicosanoid biosynthesis is initiated by the prostaglandin H 2 synthases, PGHS-1 and PGHS-2.
Although similar in structure, PGHS-1 and PGHS-2 have distinct roles. PGHS-1 is constitutively expressed in most tissues and has homeostatic functions, while PGHS-2 is inducible and found mainly at sites of inflammation (3, 4) . PGHS enzymes are glycosylated membrane proteins that are dimeric. Each dimer consists of identical monomers of 70 kDa and contain three domains: an epidermal growth factor domain, a membrane binding domain, and a catalytic domain comprising the cyclooxygenase and hemecontaining peroxidase active sites (5) . PGHS metabolizes the substrate arachidonic acid to prostaglandin G 2 (PGG 2 ) and prostaglandin H 2 (PGH 2 ) in two sequential reactions. The cyclooxygenase site binds arachidonic acid and converts it to PGG 2 , which is then reduced to the cyclic endoperoxide PGH 2 by the heme-containing peroxidase site (6) (7) (8) . The cyclooxygenase site is the target for nonsteroidal anti-inflammatory drugs, such as aspirin and ibuprofen, which interfere with the binding of arachidonic acid (7) . During catalysis, the enzyme undergoes irreversible self-inactivation (9) . The generation of a ferryl-oxo porphyrin intermediate, followed by tyrosine radical formation at Tyr 385, is thought to be essential for activation/inactivation (6, 10) . Others have suggested that a cluster of aromatic amino acids in the vicinity of the heme group in addition to Tyr 385 can form radicals involved in enzyme catalysis and inactivation (11) . Recently, it was shown that the process of PGHS-1 oxidantdriven inactivation is altered by inhibitor-binding to the cyclooxygenase channel, which likely leads to radical formation at a site different to Tyr 385 (12) . Key unresolved questions include the mechanism(s) of PGHS suicide inactivation, the factors that contribute to its deactivation as well as the involvement of enzyme modification in these processes. Evidence suggests that nitrogen oxide species (NO x ) species modulate PGHS activity and eicosanoid production under physiological conditions (13, 14) . Investigations of the direct effect of NO and NO-derived species on purified PGHS-1 enzyme activity have been controversial with reports of activation (15) (16) (17) (18) as well as inhibition (19) Finally, ONOO -nitrates purified PGHS-1 in the absence of arachidonate (24, 25) and PGHS-1 is nitrated in human atherosclerotic lesions (24) . It has been shown that tetranitromethane (TNM) and ONOO -nitrate 2 Tyr residues/PGHS-1 monomer, resulting in loss of enzyme function (24) (25) (26) . It is likely that one of the Tyr residues nitrated is Tyr 385 and in fact, it has been shown that NO from NOC-9 (27) and TNM (28) lead to Tyr 385 nitration in PGHS-1.
In this study, we investigated the role of the peroxidase heme on NO x -induced modification and loss of function in PGHS-1. In particular, the NO x species that we used in our studies included ONOO -, SIN-1 (which produces low levels of superoxide and NO that form ONOO -), NOC-7 (which produces NO), nitrite (NO -2 ) and nitrate (NO -3 ). We demonstrate that the active heme center of PGHS-1 regulates ONOO --induced modification and loss of enzyme reactivity. These modifications are manifested as change in PGHS-1 solvent accessibility and heme absorption characteristics, Tyr nitration and multimer formation. We also show that in the absence of heme, PGHS-1 Tyr nitration occurs, but not at Tyr 385 and with no impact on the ability of PGHS-1 to reconstitute heme and metabolize arachidonic acid. 
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MATERIALS AND METHODS
Ram seminal vesicles were obtained from Pel Freeze. Heptaoxyethylene decyl ether (C 10 E 7 ), diethyldithiocarbamate (DEDTC), Hemin chloride (hemin), hematin, GSH, GSH Peroxidase, sodium nitrite, sodium nitrate, tetranitromethane (TNM), CHAPS, Tween-20 and Lys-C endoproteinase were obtained from Sigma-Aldrich (minimum 95% purity; HPLC grade). 1-hydroxy-2-oxo-3-(N-methylaminopropyl)-3-methyl-1-triazene (NOC-7) was purchased from Alexis Biochemicals. Arachidonic acid (99% purity, by capillary GC) was obtained from Sigma-Aldrich and solubilized in ethanol and stored in aliquots (168 mM) at -80°C. N,N,N',N'-tetramethylphenylenediamine (TMPD), also from Sigma-Aldrich, was prepared freshly for each experiment as a 1 mg/ml stock solution. Aspirin, SIN-1 and L-NAME were purchased from Cayman Chemicals. N-Decyl-β-D-maltopyranoside (C 10 M) and Noctyl-β-D-glucopyranoside (βOG) were purchased from Anatrace. Sodium peroxynitrite (170 -200 mM in 4.7% sodium hydroxide) was obtained from Calbiochem. Monoclonal 3-nitrotyrosine antibody (clone 1A6) was obtained from Upstate biotechnology. Monoclonal PGHS-1 antibody was obtained from Cayman. Anti-mouse horseradish peroxidase conjugated IgG and ECL Plus reagents were obbtained from GE Healthcare. All materials for SDS-PAGE and Western Blotting were obtained from Bio-Rad Laboratories. Fastflow DEAE-Sepharose, S-200 and S-300 beads were purchased from GE Healthcare.
Isolation and Purification of PGHS-1 from Ram Seminal Vesicles. PGHS-1 solubilized in
Tween-20, was purified from ram seminal vesicles (300 g) as previously described by Ouderaa et al. (29) . When using CHAPS or βOG, Purified PGHS-1 was obtained by the procedure described by Malkowski et al. (30) , although we implemented modifications described below to enable purification by regular flow liquid chromatography. Concentrations of detergents used in purifications were chosen based on the published literature (29, 30) . Levels of detergent used in our experiments are the residual amounts present that result from the purification process. For PGHS-1 solubilized in CHAPS or βOG, by guest, on October 14, 2017 www.jlr.org Downloaded from 6 microsomal homogenates obtained in the absence of detergent were extracted with C 10 E 7 and C 10 M and stored at -80 °C.
Frozen microsomal extracts (70 ml) were rapidly thawed and loaded on a fast-flow DEAEsepharose column (20 cm x 1.5 cm) pre-equilibrated with wash buffer (10 mM Tris, 10 mM Bis-Tris, 1 mM NaN 3 , 0.15% C 10 M, pH 8.5). Figure 1A shows the chromatogram for the elution profile described below. The column was washed with two column volumes (V 0 =40 ml) of equilibration buffer followed by a linear pH gradient I (rate: 2 ml/min) [(40 ml) 10 mM Tris, 10 mM Bis-Tris, 1 mM NaN 3 , 0.15% C 10 M, pH 8.5 to (40 ml) 40 mM Tris, 40 mM Bis-Tris, 20 mM NaCl, 1 mM NaN 3 , 0.05 mM EDTA, 0.1 mM DEDTC, 0.15% C 10 M, pH 6.5] . Note that during the column wash stage, a major protein band (peak a), which has no PGHS-1 activity eluted off the column ( Figure 1A ). Active PGHS-1 eluted from the column with a salt gradient II (40 ml: 40 mM Tris, 40 mM Bis-Tris, 20 mM NaCl, 1 mM NaN 3 , 0.05 mM EDTA, 0.1 mM DEDTC, 0.15% C 10 M, pH 6.5 to 40 ml: 40 mM Tris, 40 mM Bis-Tris, 500 mM NaCl, 1 mM NaN 3 , 0.05 mM EDTA, 0.1 mM DEDTC, 0.15% C 10 M, pH 6.5). Highly active fractions of ~90% apoPGHS-1 eluted off the column ~30 ml into gradient II, in a sharp and narrow band ( Figure 1A , peak b). Peak b´ represents the fractions absorbing at 412 nm (the Soret band) that are holoPGHS-1 (~10%). The second band to follow ( Figure 1A , peak c) was broader and contained more heme (peak c´), but was significantly less active than peak b fractions. Fractions from peak b were combined, concentrated and desalted on a S-300 gel filtration column for use in this study.
ApoPGHS-1 was concentrated on ultra-15 spin concentrators (50 kDa cut-off, Millipore Corp.) to less than 5 ml. The concentrate was adjusted to 1% (w/v) C 10 M and loaded on a S-300 column (80 cm x 2.5 cm) pre-equilibrated with 20 mM Tris, 50 mM NaCl, 1 mM NaN 3 , 0.1 mM EDTA, 0.1 mM DEDTC, 0.15% C 10 M, pH 8. An active peak with a trailing shoulder eluted off the S-300 column (data not shown). Fractions containing the active peak were pooled, concentrated to 2 ml and adjusted to either 1% (w/v) βOG or CHAPS. Detergent was exchanged on a S-200 column (80 cm x 2.5 cm) preequilibrated with 100 mM Tris, 5 mM GSH, 5 mM EDTA, 0.3 mM DEDTC, and 0.3% (w/v) βOG (or by guest, on October 14, 2017 www.jlr.org Downloaded from 0.4% (w/v) CHAPS), pH 8.0. A single active peak eluted from the column and the protein content in each fraction was determined by using the Bio-Rad protein assay, measuring A 595 . The use of GSH during the last step removed residual heme from PGHS-1. Purified apoPGHS-1 was then concentrated and exchanged into appropriate buffers without GSH to prevent its interference in reactions described below.
Protein identity and purity were confirmed by Western blot analysis, SDS-PAGE (10% acrylamide), amino acid sequencing and mass spectrometric analysis of peptide fragments from PGHS-1 digests which is briefly described. The band corresponding to PGHS-1 was excised from a SDS-PAGE gel, washed, trypsin digested and the peptides extracted and lyophilized. Molecular mass analysis on the peptide digests from gels was performed by matrix-assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry using an Applied Biosystems ABI4700 TOF/TOF mass spectrometer were exchanged into detergent free buffer using centricon spin filters, and mixed in a 1:1 ratio with sinapinic acid solution (10 mg/ml in 50% acetonitrile, 50% H 2 O, 0.1% TFA). Samples were applied to a target plate for MALDI-TOF analysis using a Voyager DE Pro (Applied Biosystem) MALDI-TOF mass spectrometer in reflectron mode.
LC-MS/MS Analysis of Nitrated PGHS-1 and Database Search:
Nanoflow liquid chromatography-tandem mass spectrometry (nLC-MS/MS) was used to identify sites of tyrosine nitration in peptides from apoPGHS-1 and holoPGHS-1 treated with ONOO -and SIN-1. Analyses were performed using an 1100 series LC/MSD XCT plus or an 1100 series LC/MSD XCT ultra ion trap mass spectrometer with a chip cube (Agilent). The mobile phases were 0.1% formic acid in 3% acetonitrile in Western blot analysis (described below).
Modification of PGHS-1 with Aspirin.
Samples of soluble aspirin (0.5 mM) were prepared freshly from a 10 mM stock. To prepare 10 mM stock solutions, aspirin was first solubilized in 70%
ethanol followed by dilution with 0.9% NaCl. Aspirin was reacted with PGHS-1 at a 2.5 to 1.0 molar ratio for 10 min prior to performing cyclooxygenase-peroxidase coupled assays (described below). βOG and 0.03% Tween-20. Proteolysis was stopped by the addition of SDS/mercaptoethanol followed by rapid boiling for 5 min and separation on SDS-PAGE (10% acrylamide).
Proteolysis of PGHS-1 and NO x -treated PGHS-1 with LysC
PGHS-1 Activity Assays.
A peroxidase assay was used to measure PGHS-1 activity. This assay monitors the oxidation of TMPD by changes in absorbance at 611 nm following activation (33, 34) . In some experiments, ONOO -was used as the activating species.
In other experiments, the cyclooxygenase binding site substrate arachidonic acid was used as the activating species. We refer to assays using arachidonic acid as coupled cyclooxygenase-peroxidase assays. The standard reaction mixture in a spectrophotometer cuvette contained 1 ml Tris buffer ( Statistical analysis. All results were reproduced at least three times. Where appropriate, data are reported as averages ± SEM with significant differences determined by student's t-Test. A p<0.05 is statistically significant. Image J (version 1.34s) was used to quantify Western blot and SDS-PAGE band densities (NIH, USA).
RESULTS
Purification of Ovine PGHS-1. Purification of detergent-extracted PGHS-1 on an anion
exchange DEAE-sepharose column ( Figure 1A ) is a critical step as it reduces the amount of PGHS-1 bound to natural lipids, allowing control of the detergent environment (35) . 
Hemin-Reconstituted PGHS-1 is Stable and Active in βOG.
To determine the form of heme and detergent that best stabilizes active PGHS-1, purified apoPGHS-1 in Tween-20, CHAPS, C 10 M, or βOG, was reconstituted with hemin or hematin to yield a holoPGHS-1 concentration of 10 µM (Table I ). The concentration of holoPGHS-1 was calculated from the absorbance at 412 nm using a molar extinction coefficient of 142,000 M -1 cm -1
(described in Materials and Methods). Table I shows that with all four detergents, a larger amount of heme is incorporated into apoPGHS-1 when it is supplied as hemin. This is evident from the lower concentrations of hemin required to reconstitute identical apoPGHS-1 samples.
Conversely, the concentration of free hematin in solution for each trial exceeds that of free hemin. (Table I) . For optimal activity, all subsequent experiments described herein used PGHS-1 solubilized in βOG and holoPGHS-1 reconstituted with hemin. Figure 2B ). Figure 2A shows that when we measure peroxidase activity in the presence of arachidonic acid (25 µM), activity was significantly inhibited by aspirin. In contrast, Figure 2B shows that ONOO Px/GSH, indicating that GSH-Px/GSH interferes with heme reconstitution of PGHS-1. In fact, addition of fresh hemin actually resulted in the Soret band intensity increasing to levels observed in Figure 6A (data not shown) which may account for the increased activity. Alternatively, a dose response study of showed a significant improvement compared to EtOH and L-NAME. Activity assays were also performed using a range of scavenger concentrations (described in Methods) with results identical to those observed in Figure 7 . These results suggest that loss of PGHS-1 activity is mediated by a direct action of ONOO 
DISCUSSION
In these studies, we developed conditions to prepare large quantities of purified PGHS-1 using regular flow liquid chromatography (Figure 1 ). It was critical to determine PGHS-1 detergent solubilization and heme reconstitution conditions that limited enzyme inactivation or denaturation and allowed for reproducible activity. We found that βOG was most stabilizing to enzyme activity while the commonly used Tween-20 was least stabilizing. In addition, we found that the detergent influences the structure of PGHS-1. In this regard, PGHS-1 proteolysis was limited when solubilized in βOG compared to Tween-20 ( Figure 1 ) suggesting that PGHS-1 possesses a more ordered structure in βOG.
Reconstitution profiles with hemin and the more commonly used hematin (Table I) indicated that with all four solubilization detergents, hemin incorporated more readily into apoPGHS-1 especially when βOG was the detergent of choice. It is possible that the propensity of hematin to form µ-oxo dimers (41) interferes with PGHS-1 reconstitution and may explain the reason for the larger concentrations of hematin required, compared to hemin. In summary, solubilization of PGHS-1 in βOG and reconstitution with hemin provided the most optimal conditions for solution studies with purified PGHS-1.
This study implemented peroxidase assays to investigate the peroxidase activity of PGHS-1. It is known that binding of arachidonic acid to the cyclooxygenase binding site generates the cyclic endoperoxide PGG 2 , which is reduced to PGH 2 at the peroxidase site. Therefore, when using arachidonic acid, the peroxidase assay actually measures a coupled-cyclooxygenase peroxidase function.
Our studies using aspirin show that ONOO -acts solely at the peroxidase site of PGHS-1, and independently of the cyclooxygenase site ( Figure 2 ). It is important to note here that although ONOO -concentrations used in this study (250 µM) are seemingly high, the active species is extremely short- Using the cyclooxygenase-coupled peroxidase assay, we investigated whether PGHS-1 can be activated following NO x exposure. For these experiments, we measured enzymatic activity at different times following incubation of apoPGHS-1 and holoPGHS-1 with NO x (Figure 3, A and B) . HoloPGHS-1, exposed to ONOO -for 2 min, could not metabolize arachidonic acid whereas apoPGHS-1 activity was not dampened under these conditions. Incubation of holoPGHS-1 with SIN-1 which provides a system that slowly and continuously delivers low levels of both superoxide (7.02 µM/min) and NO (3.68 µM/min) (37) that combine at rates near the diffusion-controlled limit to form ONOO - (43) , also resulted in an extensive activity loss, but at a slower rate than directly added ONOO While S-nitroso-N-acetylpenicillamine (SNAP), an agent that S-nitrosates Cys residues (46) had no effect on PGHS-1 activity (15, 17) , it was recently reported that S-nitrosation enhances activation of PGHS-2 (18). ONOO -has been reported to generate S-nitrosoglutathione (GSNO 2 ) from GSH (47) and SIN-1; importantly, this residue is critical to enzyme activity (11, 28) . A similar phenomenon has been described for ferric hemoglobin and cytochrome P450 in the presence of ONOO - (50, 51) . We conclude that in the presence of ONOO -, the heme group of PGHS-1 catalyzes its own demise by inducing nitration of a Tyr residue that is critical for activity. As such, we propose a possible heme-catalyzed mechanism that leads to ONOO -nitration of the internal Tyr 385 residue that is critical to PGHS-1 activity (Figure 9 ). In the proposed scheme, overall Tyr nitration and multimer formation in holoPGHS-1, as compared to apoPGHS-1. We propose that heme plays a decisive role in catalyzing these processes in PGHS-1, and potentially other hemoproteins that become exposed to nitrative stress in an inflammatory setting. 
